AzTrials
AzTrials

Gastroesophageal Reflux DiseaseNCT06773702

Evaluation of Upper Esophageal Sphincter Motor Activity in Patients with Extra Esophageal Reflux Symptoms

An observational study of Gastroesophageal Reflux Disease, run by IRCCS Azienda Ospedaliero-Universitaria di Bologna at 1 site in Italy.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

To evaluate the presence of motor changes of the upper esophageal sphincter detectable by high-resolution manometry in patients with oropharyngeal symptoms referable to extra-esophageal reflux manifestations. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Gastroesophageal Reflux Disease
What is being tested?
gastroenterology and otolaryngological evaluation
How many people
50 participants
Where
1 siteItaly
Study dates
20 Mar 2020to 20 Mar 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All referral patients to the Gastrointestinal Functional Exploration outpatient clinic with symptoms of laryngo-pharyngeal reflux who need to have gastroenterologic evaluation by esophageal manometry, 24-hour Ph impedance testing, and ENT evaluation by laryngoscopy and who meet the inclusion criteria will be considered.

Who may be able to join

  • Age between 18 and 80 years.
  • Patients with laryngopharyngeal reflux symptoms.
  • Obtaining informed consent. Exclusion criteria.
  • Patients with tobacco habit.
  • Patients with occupational exposure to irritants (artisans and industrial workers).

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    Bologna, Bologna, 40138

Other trials in Italy

About this study

Official title: Valutazione Dell'attività Motoria Dello Sfintere Esofageo Superiore Nei Pazienti Con Sintomi Extra Esofagei Da Reflusso

To evaluate the presence of motor changes of the upper esophageal sphincter detectable by high-resolution manometry in patients with oropharyngeal symptoms referable to extra-esophageal reflux manifestations.

Read the detailed description

Gastroesophageal reflux disease (GERD) is a condition that occurs when the passage of gastric contents into the esophagus becomes clinically symptomatic and results in the appearance of complications. The incidence is higher in countries with high socioeconomic status; in fact, the prevalence in the US is estimated to be between 15 and 30 percent of the population compared with 5 to 10 percent in eastern countries such as China. 1 Typical manifestations are heartburn and acid regurgitation; however, in some cases it may manifest with extraesophageal symptoms, termed atypical, resulting from the involvement of anatomical areas of otolaryngological and pulmonary relevance.

According to the 2006 Montreal classification (Figure 1), still the reference of gastroesophageal reflux disease, the disease can manifest with:

  1. esophageal syndrome, subdivided into:
  • symptomatic, without esophageal injury (typical reflux syndrome, Chest pain syndrome)
  • syndrome with esophageal damage (esophagitis, stenosis, Barrett's esophagus and Adenocarcinoma of the esophagus)
  1. extraesophageal syndrome, subdivided into:
  • association with established reflux disease (chronic cough, laryngitis, asthma, dental erosions)
  • association with proposed reflux disease (pharyngitis, sinusitis, idiopathic pulmonary fibrosis, recurrent otitis media).

A study performed by Francis DO in the United States in 2013 showed how the management of extra esophageal reflux disease substantially burdens public spending. In fact, it was found that the cost for the first year of evaluation and treatment of patients presenting with extra esophageal reflux symptoms is five times higher than the management of typical esophageal reflux disease. The cause of this discrepancy is precisely the absence of a definitive diagnosis and standard treatment, which result in difficult management of the disease.

While there is ample literature regarding the association between MRGE and alteration of the lower esophageal sphincter, little is described about the correlation between alterations in pharyngo-laryngeal motor activity and the upper esophageal sphincter in patients with extraesophageal reflux disease symptoms.

Indeed, it is hypothesized that the reflux of acidic material at the level of the larynx may be due to a dysfunction of the sphincter that acts as an escape valve between the esophagus and pharyngo-larynx. With the development of high-resolution manometry, which, unlike conventional manometry, has no spatial gaps and allows for a faithful representation of esophageal motor function in time and space, a detailed study of oropharyngeal and upper esophageal sphincter motor activity can be achieved

The observational, non-interventional nature of the study is based on two main elements:

  1. the evaluation of data obtained from high-resolution esophageal manometry in patients with extra-esophageal reflux symptoms
  2. the comparison of data obtained from high-resolution esophageal manometry with 24-hour PH-impedancemetry and otolaryngological scores of laryngopharyngeal reflux (Reflux symptom Index, Reflux Finding Score) Patients participating in the study will not undergo any procedures beyond normal daily clinical practice; likewise, the clinical variables that will be collected for the study are those that are commonly collected by the physician in daily clinical practice.
Being tested
gastroenterology and otolaryngological evaluation
Medical subject headings
Gastroesophageal Reflux

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • gastroenterology and otolaryngological evaluationOther

    • Gastroenterology evaluation: presence and intensity of esophageal symptoms of gastro esophageal reflux disease, high-resolution esophageal manometry, and 24-hour pH-impedancometry in the absence of PPI therapy.
    • otolaryngological evaluation: presence and intensity of laryngopharyngeal reflux symptoms, laryngoscopy.
Study groups in NCT06773702
Study groupRoleWhat they receive
Patients with laryngopharyngeal reflux symptomsGastroenterological evaluation by esophageal manometry, 24-hour Ph impedance testing, Otolaryngological evaluation by laryngoscopy
Receives: Other: gastroenterology and otolaryngological evaluation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluate the presence of motor changes of the upper esophageal sphincter detectable on high-resolution manometry in patients with oropharyngeal symptoms referable to extra-esophageal reflux manifestations.

    Evaluate the presence of motor changes of the upper esophageal sphincter detectable on high-resolution manometry in patients with oropharyngeal symptoms referable to extra-esophageal reflux manifestations.

    Measured: 1 year

Secondary outcomes (3)
  1. PH-impedancemetry

    The secondary objectives of the study are contingent on the actual presence of manometric alterations of the upper esophageal sphincter in patients with extraesophageal syndrome. Basically, if no manometric changes are present, secondary objectives will: assess the association between manometric changes and the result of PH-impedancemetry

    Measured: 1 year

  2. Reflux Index Score

    The secondary objectives of the study are contingent on the actual presence of manometric alterations of the upper esophageal sphincter in patients with extraesophageal syndrome. Basically, if no manometric changes are present, secondary objectives will: evaluate the association between manometric alterations and the result of Reflux Index Score

    Measured: 1 year

  3. Reflux Symptom Index

    The secondary objectives of the study are contingent on the actual presence of manometric alterations of the upper esophageal sphincter in patients with extraesophageal syndrome. Basically, if no manometric changes are present, secondary objectives will: evaluate the association between manometric alterations and the result of the Reflux Symptom Index

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2025
  2. Study start20 Mar 2020
  3. Primary completion20 Mar 2021
  4. Study completion20 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06773702
Sponsor's protocol ID
VAM-SES-SEER2019
Status last verified
Nov 2024
First submitted
3 Dec 2024
Last updated
14 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Gastroesophageal Reflux Disease, run by IRCCS Azienda Ospedaliero-Universitaria di Bologna at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 14 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluate the presence of motor changes of the upper esophageal sphincter detectable on high-resolution manometry in patients with oropharyngeal symptoms referable to extra-esophageal reflux manifestations. (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in